PRO-04 / Prothix 
Welcome,         Profile    Billing    Logout  
 0 Diseases   0 Trials   0 Trials   0 News 
  • ||||||||||  PRO-04 / Prothix
    PRO 04 - PRO: Updates in Lung Cancer Management (Room 33) -  Aug 22, 2023 - Abstract #ASTRO2023ASTRO_93;    
    This session will cover 4 main topics: 1) The current standard of care for management of stage III non small cell lung cancer, 2) Palliation of common issues such as hemoptysis, airway obstruction, and chest pain. 3) Management of patients ineligible for chemotherapy due to poor performance status/comorbidities 4) Comparison and contrast of volume definition in small cell lung cancer, prior to chemotherapy initiation, during chemotherapy (Cycle 2 or later, and as consolidation after initial course of chemotherapy for extensive stage is complete.
  • ||||||||||  PRO-04 / Prothix
    PRO 04 - PRO: Socioeconomic Session 1) Career Advancement for the Physician in Healthcare Organizations 2) Socioeconomic Update (Henry B. Gonzalez Convention Center, Hemisfair Ballroom C2/C3) -  Aug 1, 2022 - Abstract #ASTRO2022ASTRO_84;    
    Attendees will also be updated on the status of Alternative Payment Models and on socioeconomic changes for 2023. To participate in Q&A or polls go to www.astro.org/AMSocialQA.Develop a deeper appreciation of the challenges, knowledge and skill sets needed to lead one's practice in this changing practice environment.Demonstrate an understanding of the upcoming and current socioeconomic and coding and coverage issues related to radiation oncology.
  • ||||||||||  PRO-04 / Prothix, testosterone + progesterone (ARG103) / arGentis
    Journal:  A Low-Activity Polymorphic Variant of Human NEIL2 DNA Glycosylase. (Pubmed Central) -  Mar 29, 2022   
    The P304T variant was also less proficient than the wild-type, or R103W hNEIL2, in the removal of damaged bases from single-stranded and bubble-containing DNA. Overall, hNEIL2 P304T could be worthy of a detailed epidemiological analysis as a possible cancer risk modifier.
  • ||||||||||  PRO-04 / Prothix
    [VIRTUAL] PRO 04 - Lung Cancer: Case Based Discussion (McCormick Place West, Room W196 a/b/c) -  Oct 30, 2021 - Abstract #ASTRO2021ASTRO_72;    
    Be sure to log in. To participate in Q&A or polls go to www.astro.org/AMSocialQA Explain best practice in the use of stereotactic ablative body radiation for treatment of early stage lung cancer; analyze how to approach challenging situations such as central tumors Discuss contemporary radiation approaches in the treatment of stage III NSCLC; determine how to approach tumors in close proximity to critical structures.
  • ||||||||||  PRO-04 / Prothix
    [VIRTUAL] PRO 04 - Gastrointestinal Cancer: Case Based Discussion (T.J. Eichler Theater, PRO Program) -  Sep 13, 2020 - Abstract #ASTRO2020ASTRO_201;    
    Explain and discuss rationale for outlining radiation target volumes for upper and lower GI malignancies. Analyze recently published data and discuss ongoing trials in the management of GI cancers.
  • ||||||||||  PRO-04 / Prothix
    PRO 04 - (INTERACTIVE) Clinical Cases in Gynecologic Oncology (Room W196) -  Sep 24, 2019 - Abstract #ASTRO2019ASTRO_2644;    
    Apply current guidelines in radiation therapy of cervix and endometrial cancer to clinical practice3. Discuss and analyze relevant clinical trial data pertaining to the management of cervix and endometrial cancer